{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cancer treatment", "cisplatin", "combination therapy", "modes of action", "natural products"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35163459", "DateCompleted": {"Year": "2022", "Month": "03", "Day": "16"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "28"}], "Language": ["eng"], "ELocationID": ["1532", "10.3390/ijms23031532"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "23", "Issue": "3", "PubDate": {"Year": "2022", "Month": "Jan", "Day": "28"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy.", "Abstract": {"AbstractText": ["Cisplatin and other platinum-based drugs, such as carboplatin, ormaplatin, and oxaliplatin, have been widely used to treat a multitude of human cancers. However, a considerable proportion of patients often relapse due to drug resistance and/or toxicity to multiple organs including the liver, kidneys, gastrointestinal tract, and the cardiovascular, hematologic, and nervous systems. In this study, we sought to provide a comprehensive review of the current state of the science highlighting the use of cisplatin in cancer therapy, with a special emphasis on its molecular mechanisms of action, and treatment modalities including the combination therapy with natural products. Hence, we searched the literature using various scientific databases., such as MEDLINE, PubMed, Google Scholar, and relevant sources, to collect and review relevant publications on cisplatin, natural products, combination therapy, uses in cancer treatment, modes of action, and therapeutic strategies. Our search results revealed that new strategic approaches for cancer treatment, including the combination therapy of cisplatin and natural products, have been evaluated with some degree of success. Scientific evidence from both in vitro and in vivo studies demonstrates that many medicinal plants contain bioactive compounds that are promising candidates for the treatment of human diseases, and therefore represent an excellent source for drug discovery. In preclinical studies, it has been demonstrated that natural products not only enhance the therapeutic activity of cisplatin but also attenuate its chemotherapy-induced toxicity. Many experimental studies have also reported that natural products exert their therapeutic action by triggering apoptosis through modulation of mitogen-activated protein kinase (MAPK) and p53 signal transduction pathways and enhancement of cisplatin chemosensitivity. Furthermore, natural products protect against cisplatin-induced organ toxicity by modulating several gene transcription factors and inducing cell death through apoptosis and/or necrosis. In addition, formulations of cisplatin with polymeric, lipid, inorganic, and carbon-based nano-drug delivery systems have been found to delay drug release, prolong half-life, and reduce systemic toxicity while other formulations, such as nanocapsules, nanogels, and hydrogels, have been reported to enhance cell penetration, target cancer cells, and inhibit tumor progression."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Environmental Toxicology Research Laboratory, NIH-RCMI Center for Health Disparities Research, Jackson State University, Jackson, MS 39217, USA."}], "LastName": "Dasari", "ForeName": "Shaloam", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Environmental Toxicology Research Laboratory, NIH-RCMI Center for Health Disparities Research, Jackson State University, Jackson, MS 39217, USA."}], "LastName": "Njiki", "ForeName": "Sylvianne", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Environmental Toxicology Research Laboratory, NIH-RCMI Center for Health Disparities Research, Jackson State University, Jackson, MS 39217, USA."}], "LastName": "Mbemi", "ForeName": "Ariane", "Initials": "A"}, {"Identifier": ["0000-0002-1836-0720"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, College of Science and Technology, Florida Agricultural and Mechanical University, 1610 S. Martin Luther King Blvd, Tallahassee, FL 32307, USA."}], "LastName": "Yedjou", "ForeName": "Clement G", "Initials": "CG"}, {"Identifier": ["0000-0002-3407-6674"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Environmental Toxicology Research Laboratory, NIH-RCMI Center for Health Disparities Research, Jackson State University, Jackson, MS 39217, USA."}], "LastName": "Tchounwou", "ForeName": "Paul B", "Initials": "PB"}], "GrantList": [{"GrantID": "U24 MD015970", "Acronym": "MD", "Agency": "NIMHD NIH HHS", "Country": "United States"}, {"GrantID": "U54MD015929", "Acronym": "NH", "Agency": "NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "Q20Q21Q62J", "NameOfSubstance": "Cisplatin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Biological Products"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Cisplatin"}, {"QualifierName": [], "DescriptorName": "Drug Compounding"}, {"QualifierName": [], "DescriptorName": "Drug Synergism"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Regulatory Networks"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "National Cancer Institute Cancer Statistics\u2014National Cancer Institute.  [(accessed on 27 April 2018)]; Available online:  https://www.cancer.gov/about-cancer/understanding/statistics."}, {"Citation": "Islami F., Goding Sauer A., Miller K.D., Siegel R.L., Fedewa S.A., Jacobs E.J., McCullough M.L., Patel A.V., Ma J., Soerjomataram I., et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J. Clin. 2018;68:31\u201354. doi: 10.3322/caac.21440.", "ArticleIdList": ["10.3322/caac.21440", "29160902"]}, {"Citation": "New Treatments Spur Sharp Reduction in Lung Cancer Mortality Rate. Oncol. Times. 2020;42:28. doi: 10.1097/01.COT.0000697508.45944.44.", "ArticleIdList": ["10.1097/01.COT.0000697508.45944.44"]}, {"Citation": "Henley S.J., Ward E.M., Scott S., Ma J., Anderson R.N., Firth A.U., Thomas C.C., Islami F., Weir H.K., Lewis D.R., et al. Annual Report to the Nation on the Status of Cancer, Part I: National Cancer Statistics. Cancer. 2020;126:2225\u20132249. doi: 10.1002/cncr.32802.", "ArticleIdList": ["10.1002/cncr.32802", "PMC7299151", "32162336"]}, {"Citation": "Gilman A. The initial clinical trial of nitrogen mustard. Am. J. Surg. 1963;105:574\u2013578. doi: 10.1016/0002-9610(63)90232-0.", "ArticleIdList": ["10.1016/0002-9610(63)90232-0", "13947966"]}, {"Citation": "Farber S., Diamond L.K., Mercer R.D., Sylvester R.F., Jr., Wolff J.A. Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin) N. Engl. J. Med. 1948;238:787\u2013793. doi: 10.1056/NEJM194806032382301.", "ArticleIdList": ["10.1056/NEJM194806032382301", "18860765"]}, {"Citation": "Bonadonna G., Brusamolino E., Valagussa P., Rossi A., Brugnatelli L., Brambilla C., De Lena M., Tancini G., Bajetta E., Musumeci R., et al. Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer. N. Engl. J. Med. 1976;294:405\u2013410. doi: 10.1056/NEJM197602192940801.", "ArticleIdList": ["10.1056/NEJM197602192940801", "1246307"]}, {"Citation": "Jaffe N., Frei E., Traggis D., Bishop Y. Adjuvant Methotrexate and Citrovorum-Factor Treatment of Osteogenic Sarcoma. N. Engl. J. Med. 1974;291:994\u2013997. doi: 10.1056/NEJM197411072911902.", "ArticleIdList": ["10.1056/NEJM197411072911902", "4606174"]}, {"Citation": "Skipper H.E., Thomson J.R., Elion G.B., Hitchings G.H. Observations on the anticancer activity of 6-mercaptopurine. Cancer Res. 1954;14:294\u2013298.", "ArticleIdList": ["13160953"]}, {"Citation": "Chabner B.A., Roberts T.G., Jr. Chemotherapy and the war on cancer. Nat. Rev. Cancer. 2005;5:65\u201372. doi: 10.1038/nrc1529.", "ArticleIdList": ["10.1038/nrc1529", "15630416"]}, {"Citation": "Grever M.R., Schepartz S.A., Chabner B.A. The National Cancer Institute: Cancer drug discovery and development program. Semin. Oncol. 1992;19:622\u2013638.", "ArticleIdList": ["1462164"]}, {"Citation": "Moertel C.G., Fleming T.R., Macdonald J.S., Haller D.G., Laurie J.A., Goodman P.J., Ungerleider J.S., Emerson W.A., Tormey D.C., Glick J.H., et al. Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma. N. Engl. J. Med. 1990;322:352\u2013358. doi: 10.1056/NEJM199002083220602.", "ArticleIdList": ["10.1056/NEJM199002083220602", "2300087"]}, {"Citation": "Lippert B. Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug. Wiley-VCH; New York, NY, USA: 2006."}, {"Citation": "Rosenberg B.H., Vancamp L., Trosko J.E., Mansour V.H. Platinum Compounds: A New Class of Potent Antitumour Agents. Nature. 1969;222:385\u2013386. doi: 10.1038/222385a0.", "ArticleIdList": ["10.1038/222385a0", "5782119"]}, {"Citation": "Mellor D.P. The Sterochemistry of Square Complexes. Chem. Rev. 1943;33:137\u2013183. doi: 10.1021/cr60105a003.", "ArticleIdList": ["10.1021/cr60105a003"]}, {"Citation": "Ramberg P.J. Chemical Structure, Spatial Arrangement. Routledge; London, UK: 2018. Alfred Werner and Coordination Chemistry, 1893\u20131914."}, {"Citation": "Dhara S.C. A Rapid Method for the Synthesis of Cis-[Pt(NH3)2Cl2] Indian J. Chem. 1970;8:193\u2013194."}, {"Citation": "Weiss R.B., Christian M.C. New Cisplatin Analogues in Development: A Review. Drugs. 1993;46:360\u2013377. doi: 10.2165/00003495-199346030-00003.", "ArticleIdList": ["10.2165/00003495-199346030-00003", "7693428"]}, {"Citation": "Corinti D., Coletti C., Re N., Piccirillo S., Giamp\u00e0 M., Crestoni M.E., Fornarini S. Hydrolysis of cis- and transplatin: Structure and reactivity of the aqua complexes in a solvent free environment. RSC Adv. 2017;7:15877\u201315884. doi: 10.1039/C7RA01182B.", "ArticleIdList": ["10.1039/C7RA01182B"]}, {"Citation": "Reedijk J. Increased understanding of platinum anticancer chemistry. Pure Appl. Chem. 2011;83:1709\u20131719. doi: 10.1351/PAC-CON-10-11-03.", "ArticleIdList": ["10.1351/PAC-CON-10-11-03"]}, {"Citation": "Dasari S., Tchounwou P.B. Cisplatin in cancer therapy: Molecular mechanisms of action. Eur. J. Pharmacol. 2014;740:364\u2013378. doi: 10.1016/j.ejphar.2014.07.025.", "ArticleIdList": ["10.1016/j.ejphar.2014.07.025", "PMC4146684", "25058905"]}, {"Citation": "Riddell I.A., Lippard S.J. Metallo-Drugs: Development and Action of Anticancer Agents. De Gruyter; Berlin, Germany: 2018. 1. Cisplatin and oxaliplatin: Our current understanding of their actions."}, {"Citation": "Lin X., Okuda T., Holzer A., Howell S.B. The Copper Transporter CTR1 Regulates Cisplatin Uptake in Saccharomyces cerevisiae. Mol. Pharmacol. 2002;62:1154\u20131159. doi: 10.1124/mol.62.5.1154.", "ArticleIdList": ["10.1124/mol.62.5.1154", "12391279"]}, {"Citation": "Salvesen G.S., Abrams J.M. Caspase activation\u2014Stepping on the gas or releasing the brakes? Lessons from humans and flies. Oncogene. 2004;23:2774\u20132784. doi: 10.1038/sj.onc.1207522.", "ArticleIdList": ["10.1038/sj.onc.1207522", "15077141"]}, {"Citation": "Salvesen G.S., Dixit V.M. Caspases: Intracellular Signaling by Proteolysis. Cell. 1997;91:443\u2013446. doi: 10.1016/S0092-8674(00)80430-4.", "ArticleIdList": ["10.1016/S0092-8674(00)80430-4", "9390553"]}, {"Citation": "Kuo M.T., Chen H.H.W., Song I.-S., Savaraj N., Ishikawa T. The roles of copper transporters in cisplatin resistance. Cancer Metastasis Rev. 2007;26:71\u201383. doi: 10.1007/s10555-007-9045-3.", "ArticleIdList": ["10.1007/s10555-007-9045-3", "17318448"]}, {"Citation": "Ishida S., Lee J., Thiele D.J., Herskowitz I. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc. Natl. Acad. Sci. USA. 2002;99:14298\u201314302. doi: 10.1073/pnas.162491399.", "ArticleIdList": ["10.1073/pnas.162491399", "PMC137878", "12370430"]}, {"Citation": "Yang L., Li N., Wang H., Jia X., Wang X., Luo J. Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance. Oncol. Rep. 2012;28:592\u2013600. doi: 10.3892/or.2012.1823.", "ArticleIdList": ["10.3892/or.2012.1823", "22614869"]}, {"Citation": "Lee J.-H., Chae J.-W., Kim J.K., Kim H.J., Chung J.Y., Kim Y.-H. Inhibition of cisplatin-resistance by RNA interference targeting metallothionein using reducible oligo-peptoplex. J. Control. Release. 2015;215:82\u201390. doi: 10.1016/j.jconrel.2015.07.015.", "ArticleIdList": ["10.1016/j.jconrel.2015.07.015", "26210439"]}, {"Citation": "De Luca A., Parker L.J., Ang W.H., Rodolfo C., Gabbarini V., Hancock N.C., Palone F., Mazzetti A.P., Menin L., Morton C.J., et al. A structure-based mechanism of cisplatin resistance mediated by glutathione transferase P1-1. Proc. Natl. Acad. Sci. USA. 2019;116:13943\u201313951. doi: 10.1073/pnas.1903297116.", "ArticleIdList": ["10.1073/pnas.1903297116", "PMC6628828", "31221747"]}, {"Citation": "K\u00f6berle B., Grimaldi K.A., Sunters A., Hartley J.A., Kelland L.R., Masters J.R. DNA Repair capacity and cisplatin sensitivity of human testis tumour cells. Int. J. Cancer. 1997;70:551\u2013555. doi: 10.1002/(SICI)1097-0215(19970304)70:5<551::AID-IJC10>3.0.CO;2-G.", "ArticleIdList": ["10.1002/(SICI)1097-0215(19970304)70:5<551::AID-IJC10>3.0.CO;2-G", "9052754"]}, {"Citation": "Strathdee G., MacKean M.J., Illand M., Brown R. A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer. Oncogene. 1999;18:2335\u20132341. doi: 10.1038/sj.onc.1202540.", "ArticleIdList": ["10.1038/sj.onc.1202540", "10327053"]}, {"Citation": "Wang W., Sheng W., Yu C., Cao J., Zhou J., Wu J., Zhang H., Zhang S. REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells. Oncol. Rep. 2015;34:1460\u20131468. doi: 10.3892/or.2015.4121.", "ArticleIdList": ["10.3892/or.2015.4121", "26165320"]}, {"Citation": "Rottenberg S., Jaspers J.E., Kersbergen A., Van Der Burg E., Nygren A.O.H., Zander S.A.L., Derksen P.W.B., De Bruin M., Zevenhoven J., Lau A., et al. High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs. Proc. Natl. Acad. Sci. USA. 2008;105:17079\u201317084. doi: 10.1073/pnas.0806092105.", "ArticleIdList": ["10.1073/pnas.0806092105", "PMC2579381", "18971340"]}, {"Citation": "Cho J.-M., Manandhar S., Lee H.-R., Park H.-M., Kwak M.-K. Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: Implication to cancer cell resistance. Cancer Lett. 2008;260:96\u2013108. doi: 10.1016/j.canlet.2007.10.022.", "ArticleIdList": ["10.1016/j.canlet.2007.10.022", "18036733"]}, {"Citation": "Kryczek I., Lin Y., Nagarsheth N., Peng D., Zhao L., Zhao E., Vatan L., Szeliga W., Dou Y., Owens S., et al. IL-22+CD4+ T Cells Promote Colorectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L. Immunity. 2014;40:772\u2013784. doi: 10.1016/j.immuni.2014.03.010.", "ArticleIdList": ["10.1016/j.immuni.2014.03.010", "PMC4032366", "24816405"]}, {"Citation": "Ranasinghe R., Eri R. Modulation of the CCR6-CCL20 Axis: A Potential Therapeutic Target in Inflammation and Cancer. Medicina. 2018;54:88. doi: 10.3390/medicina54050088.", "ArticleIdList": ["10.3390/medicina54050088", "PMC6262638", "30453514"]}, {"Citation": "Zhang X., Qi Z., Yin H., Yang G. Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1\u03b1-mediated regulation of apoptosis and autophagy. Theranostics. 2019;9:1096\u20131114. doi: 10.7150/thno.29673.", "ArticleIdList": ["10.7150/thno.29673", "PMC6401400", "30867818"]}, {"Citation": "Aldossary S.A. Review on Pharmacology of Cisplatin: Clinical Use, Toxicity and Mechanism of Resistance of Cisplatin. Biomed. Pharmacol. J. 2019;12:7\u201315. doi: 10.13005/bpj/1608.", "ArticleIdList": ["10.13005/bpj/1608"]}, {"Citation": "Sarin N., Engel F., Rothweiler F., Cinatl J., Michaelis M., Fr\u00f6tschl R., Fr\u00f6hlich H., Kalayda G.V. Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach. Int. J. Mol. Sci. 2018;19:767. doi: 10.3390/ijms19030767.", "ArticleIdList": ["10.3390/ijms19030767", "PMC5877628", "29518977"]}, {"Citation": "Dulz S., Asselborn N.H., Dieckmann K.-P., Matthies C., Wagner W., Weidmann J., Seidel C., Oing C., Berger L.A., Alsdorf W., et al. Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer. J. Cancer Res. Clin. Oncol. 2017;143:1319\u20131325. doi: 10.1007/s00432-017-2384-8.", "ArticleIdList": ["10.1007/s00432-017-2384-8", "28281024"]}, {"Citation": "Rubino F.M., Pitton M., Brambilla G., Colombi A. A study of the glutathione metaboloma peptides by energy-resolved mass spectrometry as a tool to investigate into the interference of toxic heavy metals with their metabolic processes. Biol. Mass Spectrom. 2006;41:1578\u20131593. doi: 10.1002/jms.1143.", "ArticleIdList": ["10.1002/jms.1143", "17136764"]}, {"Citation": "Dmitriev O.Y. Mechanism of Tumor Resistance to Cisplatin Mediated by the Copper Transporter ATP7B. Biochem. Cell Biol. 2011;89:138\u2013147. doi: 10.1139/O10-150.", "ArticleIdList": ["10.1139/O10-150", "21455266"]}, {"Citation": "Nematbakhsh M., Ashrafi F., Pezeshki Z., Fatahi Z., Kianpoor F., Sanei M.H., Talebi A. A histopathological study of nephrotoxicity, hepatoxicity or testicular toxicity: Which one is the first observation as side effect of Cisplatin-induced toxicity in animal model? J. Nephropathol. 2012;1:190\u2013193. doi: 10.5812/nephropathol.8122.", "ArticleIdList": ["10.5812/nephropathol.8122", "PMC3886150", "24475415"]}, {"Citation": "Kim H.-J., Park D.J., Kim J.H., Jeong E.Y., Jung M.H., Kim T.-H., Yang J.I., Lee G.-W., Chung H.J., Chang S.-H. Glutamine protects against cisplatin-induced nephrotoxicity by decreasing cisplatin accumulation. J. Pharmacol. Sci. 2015;127:117\u2013126. doi: 10.1016/j.jphs.2014.11.009.", "ArticleIdList": ["10.1016/j.jphs.2014.11.009", "25704027"]}, {"Citation": "Lu Y., Cederbaum A.I. Cisplatin-Induced Hepatotoxicity Is Enhanced by Elevated Expression of Cytochrome P450 2E1. Toxicol. Sci. 2006;89:515\u2013523. doi: 10.1093/toxsci/kfj031.", "ArticleIdList": ["10.1093/toxsci/kfj031", "16251482"]}, {"Citation": "Liao Y., Lu X., Lu C., Li G., Jin Y., Tang H. Selection of agents for prevention of cisplatin-induced hepatotoxicity. Pharmacol. Res. 2008;57:125\u2013131. doi: 10.1016/j.phrs.2008.01.001.", "ArticleIdList": ["10.1016/j.phrs.2008.01.001", "18282716"]}, {"Citation": "Hausheer F.H., Schilsky R.L., Bain S., Berghorn E.J., Lieberman F. Diagnosis, Management, and Evaluation of Chemotherapy-Induced Peripheral Neuropathy. Semin. Oncol. 2006;33:15\u201349. doi: 10.1053/j.seminoncol.2005.12.010.", "ArticleIdList": ["10.1053/j.seminoncol.2005.12.010", "16473643"]}, {"Citation": "Tlili N., Feriani A., Allagui M.S., Saadoui E., Khaldi A., Nasri N. Effects of Rhus tripartitum fruit extract on CCl4-induced hepatotoxicity and cisplatin-induced nephrotoxicity in rats. Can. J. Physiol. Pharmacol. 2016;94:801\u2013807. doi: 10.1139/cjpp-2016-0029.", "ArticleIdList": ["10.1139/cjpp-2016-0029", "27351070"]}, {"Citation": "Salman M., Naseem I., Hassan I., Khan A.A., Alhazza I.M. Riboflavin Arrests Cisplatin-Induced Neurotoxicity by Ameliorating Cellular Damage in Dorsal Root Ganglion Cells. BioMed Res. Int. 2015;2015:603543. doi: 10.1155/2015/603543.", "ArticleIdList": ["10.1155/2015/603543", "PMC4681007", "26759811"]}, {"Citation": "El-Awady E.-S.E., Moustafa Y.M., Abo-Elmatty D.M., Radwan A. Cisplatin-induced cardiotoxicity: Mechanisms and cardioprotective strategies. Eur. J. Pharmacol. 2011;650:335\u2013341. doi: 10.1016/j.ejphar.2010.09.085.", "ArticleIdList": ["10.1016/j.ejphar.2010.09.085", "21034734"]}, {"Citation": "Kucharz J., Michalowska-Kaczmarczyk A., Zygulska A.L., Wojtak J., Pawlik W., Herman R.M., Krzemieniecki K. Bradycardia as a rare symptom of cisplatin cardiotoxicity: A case report. Oncol. Lett. 2016;11:2297\u20132299. doi: 10.3892/ol.2016.4195.", "ArticleIdList": ["10.3892/ol.2016.4195", "PMC4774623", "26998165"]}, {"Citation": "El-Sawalhi M.M., Ahmed L.A. Exploring the protective role of apocynin, a specific NADPH oxidase inhibitor, in cisplatin-induced cardiotoxicity in rats. Chem. Interact. 2014;207:58\u201366. doi: 10.1016/j.cbi.2013.11.008.", "ArticleIdList": ["10.1016/j.cbi.2013.11.008", "24291008"]}, {"Citation": "Rybak L.P. Mechanisms of cisplatin ototoxicity and progress in otoprotection. Curr. Opin. Otolaryngol. Head Neck Surg. 2007;15:364\u2013369. doi: 10.1097/MOO.0b013e3282eee452.", "ArticleIdList": ["10.1097/MOO.0b013e3282eee452", "17823555"]}, {"Citation": "Osanto S., Bukman A., Van Hoek F., Sterk P.J., De Laat J.A., Hermans J. Long-term effects of chemotherapy in patients with testicular cancer. J. Clin. Oncol. 1992;10:574\u2013579. doi: 10.1200/JCO.1992.10.4.574.", "ArticleIdList": ["10.1200/JCO.1992.10.4.574", "1372350"]}, {"Citation": "Newman D.J., Cragg G.M., Snader K.M. Natural Products as Sources of New Drugs over the Period 1981\u22122002. J. Nat. Prod. 2003;66:1022\u20131037. doi: 10.1021/np030096l.", "ArticleIdList": ["10.1021/np030096l", "12880330"]}, {"Citation": "Sorokina M., Steinbeck C. Review on natural products databases: Where to find data in 2020. J. Cheminform. 2020;12:20. doi: 10.1186/s13321-020-00424-9.", "ArticleIdList": ["10.1186/s13321-020-00424-9", "PMC7118820", "33431011"]}, {"Citation": "Hastings J., De Matos P., Dekker A., Ennis M., Harsha B., Kale N., Muthukrishnan V., Owen G., Turner S., Williams M., et al. The ChEBI reference database and ontology for biologically relevant chemistry: Enhancements for 2013. Nucleic Acids Res. 2012;41:D456\u2013D463. doi: 10.1093/nar/gks1146.", "ArticleIdList": ["10.1093/nar/gks1146", "PMC3531142", "23180789"]}, {"Citation": "Butler M.S., Robertson A.A.B., Cooper M.A. Natural product and natural product derived drugs in clinical trials. Nat. Prod. Rep. 2014;31:1612\u20131661. doi: 10.1039/C4NP00064A.", "ArticleIdList": ["10.1039/C4NP00064A", "25204227"]}, {"Citation": "Ramirez D.A., Locatelli D.A., Gonz\u00e1lez R.E., Cavagnaro P., Camargo A.B. Analytical methods for bioactive sulfur compounds in Allium: An integrated review and future directions. J. Food Compos. Anal. 2017;61:4\u201319. doi: 10.1016/j.jfca.2016.09.012.", "ArticleIdList": ["10.1016/j.jfca.2016.09.012"]}, {"Citation": "Shoemaker H.H., Weisberger A.S., Pensky J. Tumor-Inhibiting Effects Derived from an Active Principle of Garlic (Allium Sativum) Science. 1957;126:1112. doi: 10.1126/science.126.3283.1112.a.", "ArticleIdList": ["10.1126/science.126.3283.1112.a", "13486066"]}, {"Citation": "Dahanukar S., Thatte U. Current status of ayurveda in phytomedicine. Phytomedicine. 1997;4:359\u2013368. doi: 10.1016/S0944-7113(97)80048-7.", "ArticleIdList": ["10.1016/S0944-7113(97)80048-7", "23195589"]}, {"Citation": "Surh Y.-J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer. 2003;3:768\u2013780. doi: 10.1038/nrc1189.", "ArticleIdList": ["10.1038/nrc1189", "14570043"]}, {"Citation": "Jin Z.-Y., Wu M., Han R.-Q., Zhang X.-F., Wang X.-S., Liu A.-M., Zhou J.-Y., Lu Q.-Y., Zhang Z.-F., Zhao J. Raw Garlic Consumption as a Protective Factor for Lung Cancer, a Population-Based Case\u2013Control Study in a Chinese Population. Cancer Prev. Res. 2013;6:711\u2013718. doi: 10.1158/1940-6207.CAPR-13-0015.", "ArticleIdList": ["10.1158/1940-6207.CAPR-13-0015", "PMC3718302", "23658367"]}, {"Citation": "Dreher F., Gabard B., Schwindt D.A., Maibach H.I. Topical melatonin in combination with vitamins E and C protects skin from ultraviolet-induced erythema: A human study in vivo. Br. J. Dermatol. 1998;139:332\u2013339. doi: 10.1046/j.1365-2133.1998.02447.x.", "ArticleIdList": ["10.1046/j.1365-2133.1998.02447.x", "9767255"]}, {"Citation": "Agarwal K.C. Therapeutic Actions of Garlic Constituents. Med. Res. Rev. 1996;16:111\u2013124. doi: 10.1002/(SICI)1098-1128(199601)16:1<111::AID-MED4>3.0.CO;2-5.", "ArticleIdList": ["10.1002/(SICI)1098-1128(199601)16:1<111::AID-MED4>3.0.CO;2-5", "8788216"]}, {"Citation": "Mikaili P., Maadirad S., Moloudizargari M., Aghajanshakeri S., Sarahroodi S. Therapeutic Uses and Pharmacological Properties of Garlic, Shallot, and Their Biologically Active Compounds. Iran. J. Basic Med. Sci. 2013;16:1031\u20131048. doi: 10.22038/IJBMS.2013.1865.", "ArticleIdList": ["10.22038/IJBMS.2013.1865", "PMC3874089", "24379960"]}, {"Citation": "Milner J.A. Mechanisms by Which Garlic and Allyl Sulfur Compounds Suppress Carcinogen Bioactivation: Garlic and Carcinogenesis. Adv. Exp. Med. Biol. 2001;492:69\u201381.", "ArticleIdList": ["11480676"]}, {"Citation": "Amagase H. Clarifying the Real Bioactive Constituents of Garlic. J. Nutr. 2006;136((Suppl. 3)):716S\u2013725S. doi: 10.1093/jn/136.3.716S.", "ArticleIdList": ["10.1093/jn/136.3.716S", "16484550"]}, {"Citation": "Cerella C., Dicato M., Jacob C., Diederich M. Chemical properties and mechanisms determining the anti-cancer action of garlic-derived organic sulfur compounds. Anti-Cancer Agents Med. Chem. 2011;11:267\u2013271. doi: 10.2174/187152011795347522.", "ArticleIdList": ["10.2174/187152011795347522", "21269260"]}, {"Citation": "Szychowski K.A., Binduga U.E., Rybczy\u0144ska-Tkaczyk K., Leja M.L., Gmi\u0144ski J. Cytotoxic effects of two extracts from garlic (Allium sativum L.) cultivars on the human squamous carcinoma cell line SCC-15. Saudi J. Biol. Sci. 2016;25:1703\u20131712. doi: 10.1016/j.sjbs.2016.10.005.", "ArticleIdList": ["10.1016/j.sjbs.2016.10.005", "PMC6303145", "30591788"]}, {"Citation": "Knowles L.M., Milner J.A. Possible mechanism by which allyl sulfides suppress neoplastic cell proliferation. J. Nutr. 2001;131:1061S\u20131066S. doi: 10.1093/jn/131.3.1061S.", "ArticleIdList": ["10.1093/jn/131.3.1061S", "11238817"]}, {"Citation": "Xiao D., Herman-Antosiewicz A., Antosiewicz J., Xiao H., Brisson M., Lazo J.S., Singh S.V. Diallyl trisulfide-induced G2\u2013M phase cell cycle arrest in human prostate cancer cells is caused by reactive oxygen species-dependent destruction and hyperphosphorylation of Cdc25C. Oncogene. 2005;24:6256\u20136268. doi: 10.1038/sj.onc.1208759.", "ArticleIdList": ["10.1038/sj.onc.1208759", "15940258"]}, {"Citation": "Ma H.B., Huang S., Yin X.R., Zhang Y., Di Z.L. Apoptotic pathway induced by diallyl trisulfide in pancreatic cancer cells. World J. Gastroenterol. 2014;20:193\u2013203. doi: 10.3748/wjg.v20.i1.193.", "ArticleIdList": ["10.3748/wjg.v20.i1.193", "PMC3886008", "24415872"]}, {"Citation": "Li Y., Wang Z., Li J., Sang X. Diallyl disulfide suppresses FOXM1-mediated proliferation and invasion in osteosarcoma by upregulating miR-134. J. Cell. Biochem. 2018;120:7286\u20137296. doi: 10.1002/jcb.28003.", "ArticleIdList": ["10.1002/jcb.28003", "30387181"]}, {"Citation": "Hong Y.-S., Ham Y.-A., Choi J.-H., Kim J. Effects of allyl sulfur compounds and garlic extract on the expression of Bcl-2, Bax, and p53 in non small cell lung cancer cell lines. Exp. Mol. Med. 2000;32:127\u2013134. doi: 10.1038/emm.2000.22.", "ArticleIdList": ["10.1038/emm.2000.22", "11048643"]}, {"Citation": "Wahab N.A.A., Lajis N.H., Abas F., Othman I., Naidu R. Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer. Nutrients. 2020;12:679. doi: 10.3390/nu12030679.", "ArticleIdList": ["10.3390/nu12030679", "PMC7146610", "32131560"]}, {"Citation": "Wilken R., Veena M.S., Wang M.B., Srivatsan E.S. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol. Cancer. 2011;10:12. doi: 10.1186/1476-4598-10-12.", "ArticleIdList": ["10.1186/1476-4598-10-12", "PMC3055228", "21299897"]}, {"Citation": "Priyadarsini K.I. The Chemistry of Curcumin: From Extraction to Therapeutic Agent. Molecules. 2014;19:20091\u201320112. doi: 10.3390/molecules191220091.", "ArticleIdList": ["10.3390/molecules191220091", "PMC6270789", "25470276"]}, {"Citation": "Paulucci V.P., Couto R.O., Teixeira C.C., Freitas L. Optimization of the extraction of curcumin from Curcuma longa rhizomes. Revista Brasileira de Farmacognosia. 2013;23:94\u2013100. doi: 10.1590/S0102-695X2012005000117.", "ArticleIdList": ["10.1590/S0102-695X2012005000117"]}, {"Citation": "De Oyanguren F.J.S., Rainey N.E., Moustapha A., Saric A., Sureau F., O\u2019Connor J.-E., Petit P.X. Highlighting Curcumin-Induced Crosstalk between Autophagy and Apoptosis as Supported by Its Specific Subcellular Localization. Cells. 2020;9:361. doi: 10.3390/cells9020361.", "ArticleIdList": ["10.3390/cells9020361", "PMC7072416", "32033136"]}, {"Citation": "Bose S., Panda A.K., Mukherjee S., Sa G. Curcumin and tumor immune-editing: Resurrecting the immune system. Cell Div. 2015;10:6. doi: 10.1186/s13008-015-0012-z.", "ArticleIdList": ["10.1186/s13008-015-0012-z", "PMC4603973", "26464579"]}, {"Citation": "Wang M., Jiang S., Zhou L., Yu F., Ding H., Li P., Zhou M., Wang K. Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs. Int. J. Biol. Sci. 2019;15:1200\u20131214. doi: 10.7150/ijbs.33710.", "ArticleIdList": ["10.7150/ijbs.33710", "PMC6567807", "31223280"]}, {"Citation": "Ismail N.I., Othman I., Abas F., Lajis N.H., Naidu R. Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer. Int. J. Mol. Sci. 2019;20:2454. doi: 10.3390/ijms20102454.", "ArticleIdList": ["10.3390/ijms20102454", "PMC6566943", "31108984"]}, {"Citation": "Tomeh M.A., Hadianamrei R., Zhao X. A Review of Curcumin and Its Derivatives as Anticancer Agents. Int. J. Mol. Sci. 2019;20:1033. doi: 10.3390/ijms20051033.", "ArticleIdList": ["10.3390/ijms20051033", "PMC6429287", "30818786"]}, {"Citation": "Khan A.Q., Ahmed E.I., Elareer N., Fathima H., Prabhu K.S., Siveen K.S., Kulinski M., Azizi F., Dermime S., Ahmad A., et al. Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway. Int. J. Mol. Sci. 2020;21:438. doi: 10.3390/ijms21020438.", "ArticleIdList": ["10.3390/ijms21020438", "PMC7014270", "31936675"]}, {"Citation": "Park B.H., Lim J.E., Jeon H.G., Seo S.I., Lee H.M., Choi H.Y., Jeon S.S., Jeong B.C. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2. Oncotarget. 2016;7:63870\u201363886. doi: 10.18632/oncotarget.11563.", "ArticleIdList": ["10.18632/oncotarget.11563", "PMC5325410", "27564099"]}, {"Citation": "Baharuddin P., Satar N., Fakiruddin K.S., Zakaria N., Lim M.N., Yusoff N.M., Zakaria Z., Yahaya B.H. Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines. Oncol. Rep. 2015;35:13\u201325. doi: 10.3892/or.2015.4371.", "ArticleIdList": ["10.3892/or.2015.4371", "PMC4699625", "26531053"]}, {"Citation": "Rutz J., Janicova A., Woidacki K., Chun F.K.-H., Blaheta R.A., Relja B. Curcumin\u2014A Viable Agent for Better Bladder Cancer Treatment. Int. J. Mol. Sci. 2020;21:3761. doi: 10.3390/ijms21113761.", "ArticleIdList": ["10.3390/ijms21113761", "PMC7312715", "32466578"]}, {"Citation": "Kumar B., Yadav A., Hideg K., Kuppusamy P., Teknos T.N., Kumar P. A Novel Curcumin Analog (H-4073) Enhances the Therapeutic Efficacy of Cisplatin Treatment in Head and Neck Cancer. PLoS ONE. 2014;9:e93208. doi: 10.1371/journal.pone.0093208.", "ArticleIdList": ["10.1371/journal.pone.0093208", "PMC3968069", "24675768"]}, {"Citation": "Saghatelyan T., Tananyan A., Janoyan N., Tadevosyan A., Petrosyan H., Hovhannisyan A., Hayrapetyan L., Arustamyan M., Arnhold J., Rotmann A.-R., et al. Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind, placebo-controlled clinical trial. Phytomedicine. 2020;70:153218. doi: 10.1016/j.phymed.2020.153218.", "ArticleIdList": ["10.1016/j.phymed.2020.153218", "32335356"]}, {"Citation": "Hejazi J., Rastmanesh R., Taleban F.A., Molana S.H., Ehtejab G. A Pilot Clinical Trial of Radioprotective Effects of Curcumin Supplementation in Patients with Prostate Cancer. J. Cancer Sci. Ther. 2013;5:320\u2013324. doi: 10.4172/1948-5956.1000222.", "ArticleIdList": ["10.4172/1948-5956.1000222"]}, {"Citation": "Gupta S.C., Patchva S., Aggarwal B.B. Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials. AAPS J. 2013;15:195\u2013218. doi: 10.1208/s12248-012-9432-8.", "ArticleIdList": ["10.1208/s12248-012-9432-8", "PMC3535097", "23143785"]}, {"Citation": "Gonzalez M.J., Miranda-Massari J.R. New Insights on Vitamin C and Cancer. Springer; New York, NY, USA: 2014."}, {"Citation": "Longchar A., Prasad S. Ascorbic Acid (Vitamin C)-Mediated Protection on Mutagenic Potentials of Cisplatin in Mice Bearing Ascites Dalton \u2019s Lymphoma. Res. J. Mutagen. 2016;6:1\u201321. doi: 10.3923/rjmutag.2016.1.21.", "ArticleIdList": ["10.3923/rjmutag.2016.1.21"]}, {"Citation": "Alabi Q.K., Akomolafe R.O., Olukiran O.S., Nafiu A.O., Adefisayo M.A., Owotomo O.I., Omole J.G., Olamilosoye K.P. Combined Administration ofl-Carnitine and Ascorbic Acid Ameliorates Cisplatin-Induced Nephrotoxicity in Rats. J. Am. Coll. Nutr. 2018;37:387\u2013398. doi: 10.1080/07315724.2017.1409139.", "ArticleIdList": ["10.1080/07315724.2017.1409139", "29425480"]}, {"Citation": "Ghavami G., Sardari S. Synergistic Effect of Vitamin C with Cisplatin for Inhibiting Proliferation of Gastric Cancer Cells. Iran. Biomed. J. 2020;24:119\u2013127. doi: 10.29252/ibj.24.2.119.", "ArticleIdList": ["10.29252/ibj.24.2.119", "PMC6984712", "31677606"]}, {"Citation": "Ortekin S., Kocyigit M., Yagiz R., Tas A., Bulut E., Koten M., Kanter M., Karasaliihoglu A. Assessment of protective effect of ascorbic acid in cisplatin ototoxicity on guinea pigs with electrophysiological tests and ultrastructural study: A Preliminary Study. Int. J. Surg. Med. 2019;5:88\u201393. doi: 10.5455/ijsm.Assessment-protective-effect-ascorbic-acid.", "ArticleIdList": ["10.5455/ijsm.Assessment-protective-effect-ascorbic-acid"]}, {"Citation": "Kurbacher C.M., Wagner U., Kolster B., Andreotti P.E., Krebs D., Bruckner H.W. Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett. 1996;103:183\u2013189. doi: 10.1016/0304-3835(96)04212-7.", "ArticleIdList": ["10.1016/0304-3835(96)04212-7", "8635156"]}, {"Citation": "De Martinis B.S., Bianchi M.D.L.P. Effect of vitamin C supplementation against cisplatin-induced toxicity and oxidative DNA damage in rats. Pharmacol. Res. 2001;44:317\u2013320. doi: 10.1006/phrs.2001.0860.", "ArticleIdList": ["10.1006/phrs.2001.0860", "11592867"]}, {"Citation": "Ajith T., Usha S., Nivitha V. Ascorbic acid and \u03b1-tocopherol protect anticancer drug cisplatin induced nephrotoxicity in mice: A comparative study. Clin. Chim. Acta. 2007;375:82\u201386. doi: 10.1016/j.cca.2006.06.011.", "ArticleIdList": ["10.1016/j.cca.2006.06.011", "16889761"]}, {"Citation": "Tarladacalisir Y.T., Kanter M., Uygun M. Protective Effects of Vitamin C on Cisplatin-Induced Renal Damage: A Light and Electron Microscopic Study. Ren. Fail. 2008;30:1\u20138. doi: 10.1080/08860220701742070.", "ArticleIdList": ["10.1080/08860220701742070", "18197536"]}, {"Citation": "Longchar A., Prasad S.B. Biochemical changes associated with ascorbic acid\u2013cisplatin combination therapeutic efficacy and protective effect on cisplatin-induced toxicity in tumor-bearing mice. Toxicol. Rep. 2015;2:489\u2013503. doi: 10.1016/j.toxrep.2015.01.017.", "ArticleIdList": ["10.1016/j.toxrep.2015.01.017", "PMC5598450", "28962385"]}, {"Citation": "Antunes L.M.G., Darin J.D.C., Bianchi M.D.L.P. Protective Effects of Vitamin C Against Cisplatin-Induced Nephrotoxicity and Lipid Peroxidation in Adult Rats: A Dose-Dependent Study. Pharmacol. Res. 2000;41:405\u2013411. doi: 10.1006/phrs.1999.0600.", "ArticleIdList": ["10.1006/phrs.1999.0600", "10704263"]}, {"Citation": "Aleisa A.M., Al-Majed A.A., Al-Yahya A.A., Al-Rejaie S.S., Bakheet S.A., Al-Shabanah O.A., Sayed-Ahmed M.M. Reversal of Cisplatin-Induced Carnitine Deficiency and Energy Starvation by Propionyl-L-Carnitine In Rat Kidney Tissues. Clin. Exp. Pharmacol. Physiol. 2007;34:1252\u20131259. doi: 10.1111/j.1440-1681.2007.04714.x.", "ArticleIdList": ["10.1111/j.1440-1681.2007.04714.x", "17973863"]}, {"Citation": "Ryan J.L., Heckler C.E., Roscoe J.A., Dakhil S.R., Kirshner J., Flynn P.J., Hickok J.T., Morrow G.R. Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: A URCC CCOP study of 576 patients. Support. Care Cancer. 2011;20:1479\u20131489. doi: 10.1007/s00520-011-1236-3.", "ArticleIdList": ["10.1007/s00520-011-1236-3", "PMC3361530", "21818642"]}, {"Citation": "Zhang M.-M., Wang D., Lu F., Zhao R., Ye X., He L., Ai L., Wu C.-J. Identification of the active substances and mechanisms of ginger for the treatment of colon cancer based on network pharmacology and molecular docking. BioData Min. 2021;14:1\u201316. doi: 10.1186/s13040-020-00232-9.", "ArticleIdList": ["10.1186/s13040-020-00232-9", "PMC7798235", "33430939"]}, {"Citation": "Zadorozhna M., Mangieri D. Mechanisms of Chemopreventive and Therapeutic Proprieties of Ginger Extracts in Cancer. Int. J. Mol. Sci. 2021;22:6599. doi: 10.3390/ijms22126599.", "ArticleIdList": ["10.3390/ijms22126599", "PMC8234951", "34202966"]}, {"Citation": "Lechner J.F., Stoner G.D. Gingers and Their Purified Components as Cancer Chemopreventative Agents. Molecules. 2019;24:2859. doi: 10.3390/molecules24162859.", "ArticleIdList": ["10.3390/molecules24162859", "PMC6719158", "31394732"]}, {"Citation": "Semwal R.B., Semwal D., Combrinck S., Viljoen A.M. Gingerols and shogaols: Important nutraceutical principles from ginger. Phytochemistry. 2015;117:554\u2013568. doi: 10.1016/j.phytochem.2015.07.012.", "ArticleIdList": ["10.1016/j.phytochem.2015.07.012", "26228533"]}, {"Citation": "Reddy Y.A., Chalamaiah M., Ramesh B., Balaji G., Indira P. Ameliorating activity of ginger (Zingiber officinale) extract against lead induced renal toxicity in male rats. J. Food Sci. Technol. 2011;51:908\u2013914. doi: 10.1007/s13197-011-0568-9.", "ArticleIdList": ["10.1007/s13197-011-0568-9", "PMC4008737", "24803697"]}, {"Citation": "Famurewa A.C., Ekeleme--Egedigwe C.A., Onwe C.S., Egedigwe U.O., Okoro C.O., Egedigwe U.J., Asogwa N.T. Ginger juice prevents cisplatin--induced oxidative stress, endocrine imbalance and NO/iNOS/NF--\u03baB signalling via modulating testicular redox--inflammatory mechanism in rats. Andrologia. 2020;52:e13786. doi: 10.1111/and.13786.", "ArticleIdList": ["10.1111/and.13786", "32777091"]}, {"Citation": "Ghlissi Z., Atheymen R., Boujbiha M.A., Sahnoun Z., Ayedi F.M., Zeghal K., El Feki A., Hakim A. Antioxidant and androgenic effects of dietary ginger on reproductive function of male diabetic rats. Int. J. Food Sci. Nutr. 2013;64:974\u2013978. doi: 10.3109/09637486.2013.812618.", "ArticleIdList": ["10.3109/09637486.2013.812618", "23862759"]}, {"Citation": "Wang J., Yao M., Wang Y., Ho C.-T., Li S., Shi Y., Liu Q., Zhao H. 6-Shogaol ameliorates injury to the intestinal mucosa and increases survival after high-dose abdominal irradiation. J. Funct. Foods. 2017;36:63\u201371. doi: 10.1016/j.jff.2017.06.054.", "ArticleIdList": ["10.1016/j.jff.2017.06.054"]}, {"Citation": "Chirino Y.I., Hern\u00e1ndez-Pando R., Pedraza-Chaverr\u00ed J. Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. BMC Pharmacol. 2004;4:20. doi: 10.1186/1471-2210-4-20.", "ArticleIdList": ["10.1186/1471-2210-4-20", "PMC526185", "15458572"]}, {"Citation": "Colpi G., Contalbi G., Nerva F., Sagone P., Piediferro G. Testicular function following chemo\u2013radiotherapy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2004;113:S2\u2013S6. doi: 10.1016/j.ejogrb.2003.11.002.", "ArticleIdList": ["10.1016/j.ejogrb.2003.11.002", "15041121"]}, {"Citation": "Bhat S.G., Nie Z., Ramkumar V. Cisplatin up-regulates adenosine A1 receptors in rat testes. Eur. J. Pharmacol. 1999;382:35\u201343. doi: 10.1016/S0014-2999(99)00584-1.", "ArticleIdList": ["10.1016/S0014-2999(99)00584-1", "10556502"]}, {"Citation": "T\u00fcrk G., Ate\u015f\u015fahin A., S\u00f6nmez M., Ceribasi A.O., Y\u00fcce A. Improvement of cisplatin-induced injuries to sperm quality, the oxidant-antioxidant system, and the histologic structure of the rat testis by ellagic acid. Fertil. Steril. 2008;89:1474\u20131481. doi: 10.1016/j.fertnstert.2007.04.059.", "ArticleIdList": ["10.1016/j.fertnstert.2007.04.059", "17681317"]}, {"Citation": "Rehman M.U., Ahmad S.B., Arif A., Rasool S., Farooq A., Razzaq R., Bhat S.A., Bashir S., Shabir O., Amin I., et al. Zingerone protects against cisplatin-induced oxidative damage in the jejunum of Wistar rats. Orient. Pharm. Exp. Med. 2015;15:199\u2013206. doi: 10.1007/s13596-015-0187-5.", "ArticleIdList": ["10.1007/s13596-015-0187-5"]}, {"Citation": "El-Sheikh S. E., El-Khayat Z., Hassan A.A., Mohamed N., El-Naggar M., Omara E. Possible Protective Role of Sodium Salicylate Nanoemulsion and Ginger on Cisplatin-Induced Hepatotoxicity in Rats (Biochemical and Histopathological Study) Int. J. Curr. Pharm. Res. 2020:133\u2013139. doi: 10.22159/ijcpr.2020v12i3.38323.", "ArticleIdList": ["10.22159/ijcpr.2020v12i3.38323"]}, {"Citation": "Ejoh R.A., Nkonga D.V., Inocent G., Moses M.C. Nutritional Components of Some Non-Conventional Leafy Vegetables Consumed in Cameroon. Pak. J. Nutr. 2007;6:712\u2013717. doi: 10.3923/pjn.2007.712.717.", "ArticleIdList": ["10.3923/pjn.2007.712.717"]}, {"Citation": "Yedjou C.G., Izevbigie E.B., Tchounwou P.B. Vernonia amygdalina\u2014Induced Growth Arrest and Apoptosis of Breast Cancer (MCF-7) Cells. Pharmacol. Pharm. 2013;4:93\u201399. doi: 10.4236/pp.2013.41013.", "ArticleIdList": ["10.4236/pp.2013.41013", "PMC3864043", "24353904"]}, {"Citation": "Yedjou C.G., Mbemi A.T., Noubissi F., Tchounwou S.S., Tsabang N., Payton M., Miele L., Tchounwou P.B. Prostate Cancer Disparity, Chemoprevention, and Treatment by Specific Medicinal Plants. Nutrients. 2019;11:336. doi: 10.3390/nu11020336.", "ArticleIdList": ["10.3390/nu11020336", "PMC6412894", "30720759"]}, {"Citation": "Farombi E.O., Owoeye O. Antioxidative and Chemopreventive Properties of Vernonia Amygdalina and Garcinia Biflavo-noid. Int. J. Environ. Res. Public Health. 2011;8:2533\u20132555. doi: 10.3390/ijerph8062533.", "ArticleIdList": ["10.3390/ijerph8062533", "PMC3138040", "21776245"]}, {"Citation": "Udochukwu U., Omeje F.I., Uloma I.S., Oseiwe F.D., Udochukwu U. Phytochemical Analysis of Vernonia Amyg-Dalina and Ocimum Gratissimum Extracts and Their Antibacterial Activity on Some Drug Resistant Bacteria. Am. J. Res. Commun. 2015;3:225\u2013235."}, {"Citation": "Erasto P., Grierson D.S., Afolayan A.J. Evaluation of antioxidant activity and the fatty acid profile of the leaves of Vernonia amygdalina growing in South Africa. Food Chem. 2006;104:636\u2013642. doi: 10.1016/j.foodchem.2006.12.013.", "ArticleIdList": ["10.1016/j.foodchem.2006.12.013"]}, {"Citation": "Mbemi A.T., Sims J.N., Yedjou C.G., Noubissi F.K., Gomez C.R., Tchounwou P.B. Vernonia calvoana Shows Promise towards the Treatment of Ovarian Cancer. Int. J. Mol. Sci. 2020;21:4429. doi: 10.3390/ijms21124429.", "ArticleIdList": ["10.3390/ijms21124429", "PMC7352360", "32580345"]}, {"Citation": "Johnson W., Tchounwou P.B., Yedjou C.G. Therapeutic Mechanisms of Vernonia amygdalina Delile in the Treatment of Prostate Cancer. Molecules. 2017;22:1594. doi: 10.3390/molecules22101594.", "ArticleIdList": ["10.3390/molecules22101594", "PMC5661957", "28937624"]}, {"Citation": "Lowe H., Daley-Beckford D., Toyang N., Watson C., Hartley S., Bryant J. The Anti-cancer Activity of Vernonia divaricata Sw against Leukaemia, Breast and Prostate Cancers In Vitro. West Indian Med. J. 2014;63:285\u2013288. doi: 10.7727/wimj.2013.232.", "ArticleIdList": ["10.7727/wimj.2013.232", "PMC4663936", "25429469"]}, {"Citation": "Toyang N.J., Ateh E.N., Davis H., Tane P., Sondengam L.B., Bryant J., Verpoorte R. In vivo antiprostate tumor potential of Vernonia guineensis Benth. (Asteraceae) tuber extract (VGDE) and the cytotoxicity of its major compound pentaisovaleryl sucrose. J. Ethnopharmacol. 2013;150:724\u2013728. doi: 10.1016/j.jep.2013.09.028.", "ArticleIdList": ["10.1016/j.jep.2013.09.028", "PMC4466115", "24095832"]}, {"Citation": "Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol. 2014;4:177. doi: 10.3389/fphar.2013.00177.", "ArticleIdList": ["10.3389/fphar.2013.00177", "PMC3887317", "24454289"]}, {"Citation": "Tona L., Cimanga R., Mesia K., Musuamba C., De Bruyne T., Apers S., Hernans N., Van Miert S., Pieters L., Tott\u00e9 J., et al. In vitro antiplasmodial activity of extracts and fractions from seven medicinal plants used in the Democratic Republic of Congo. J. Ethnopharmacol. 2004;93:27\u201332. doi: 10.1016/j.jep.2004.02.022.", "ArticleIdList": ["10.1016/j.jep.2004.02.022", "15182900"]}, {"Citation": "Izevbigie E.B. Discovery of Water-Soluble Anticancer Agents (Edotides) from a Vegetable Found in Benin City, Nigeria. Exp. Biol. Med. 2003;228:293\u2013298. doi: 10.1177/153537020322800308.", "ArticleIdList": ["10.1177/153537020322800308", "12626774"]}, {"Citation": "Muraina I.A., Adaudi A.O., Mamman M., Kazeem H.M., Picard J., McGaw L.J., Eloff J.N. Antimycoplasmal activity of some plant species from northern Nigeria compared to the currently used therapeutic agent. Pharm. Biol. 2010;48:1103\u20131107. doi: 10.3109/13880200903505633.", "ArticleIdList": ["10.3109/13880200903505633", "20819025"]}, {"Citation": "Erasto P., Grierson D.S., Afolayan A.J. Antioxidant Constituents inVernonia amygdalina. Leaves. Pharm. Biol. 2007;45:195\u2013199. doi: 10.1080/13880200701213070.", "ArticleIdList": ["10.1080/13880200701213070"]}, {"Citation": "Mwanauta R.W., Mtei K.A., Ndakidemi P.A. Prospective Bioactive Compounds from Vernonia amygdalina, Lippia javanica, Dysphania ambrosioides and Tithonia diversifolia in Controlling Legume Insect Pests. Agric. Sci. 2014;5:1129\u20131139. doi: 10.4236/as.2014.512123.", "ArticleIdList": ["10.4236/as.2014.512123"]}, {"Citation": "Alara O.R., Abdurahman N.H., Ukaegbu C.I., Kabbashi N.A. Extraction and characterization of bioactive compounds in Vernonia amygdalina leaf ethanolic extract comparing Soxhlet and microwave-assisted extraction techniques. J. Taibah Univ. Sci. 2019;13:414\u2013422. doi: 10.1080/16583655.2019.1582460.", "ArticleIdList": ["10.1080/16583655.2019.1582460"]}, {"Citation": "Dessie Y., Tadesse S., Eswaramoorthy R. Physicochemical parameter influences and their optimization on the biosynthesis of MnO2 nanoparticles using Vernonia amygdalina leaf extract. Arab. J. Chem. 2020;13:6472\u20136492. doi: 10.1016/j.arabjc.2020.06.006.", "ArticleIdList": ["10.1016/j.arabjc.2020.06.006"]}, {"Citation": "Yedjou C., Izevbigie E., Tchounwou P.B. Preclinical Assessment of Vernonia amygdalina Leaf Extracts as DNA Damaging Anti-cancer Agent in the Management of Breast Cancer. Int. J. Environ. Res. Public Health. 2008;5:337\u2013341. doi: 10.3390/ijerph5050337.", "ArticleIdList": ["10.3390/ijerph5050337", "PMC3699992", "19151427"]}, {"Citation": "Wong F.C., Woo C.C., Hsu A., Tan B.K.H. The Anti-Cancer Activities of Vernonia amygdalina Extract in Human Breast Cancer Cell Lines Are Mediated through Caspase-Dependent and p53-Independent Pathways. PLoS ONE. 2013;8:e78021. doi: 10.1371/journal.pone.0078021.", "ArticleIdList": ["10.1371/journal.pone.0078021", "PMC3812032", "24205071"]}, {"Citation": "Liu Y., Wang X., Li W., Xu Y., Zhuo Y., Li M., He Y., Wang X., Guo Q., Zhao L., et al. Oroxylin A reverses hypoxia-induced cisplatin resistance through inhibiting HIF-1\u03b1 mediated XPC transcription. Oncogene. 2020;39:6893\u20136905. doi: 10.1038/s41388-020-01474-x.", "ArticleIdList": ["10.1038/s41388-020-01474-x", "32978517"]}, {"Citation": "Li J., Wang Y., Lei J.-C., Hao Y., Yang Y., Yang C.-X., Yu J.-Q. Sensitisation of ovarian cancer cells to cisplatin by flavonoids fromScutellaria barbata. Nat. Prod. Res. 2013;28:683\u2013689. doi: 10.1080/14786419.2013.871547.", "ArticleIdList": ["10.1080/14786419.2013.871547", "24359131"]}, {"Citation": "Erdogan S., Turkekul K., Serttas R., Erdogan Z. The natural flavonoid apigenin sensitizes human CD44 + prostate cancer stem cells to cisplatin therapy. Biomed. Pharmacother. 2017;88:210\u2013217. doi: 10.1016/j.biopha.2017.01.056.", "ArticleIdList": ["10.1016/j.biopha.2017.01.056", "28107698"]}, {"Citation": "Kachadourian R., Leitner H., Day B. Selected flavonoids potentiate the toxicity of cisplatin in human lung adenocarcinoma cells: A role for glutathione depletion. Int. J. Oncol. 2007;31:161\u2013168. doi: 10.3892/ijo.31.1.161.", "ArticleIdList": ["10.3892/ijo.31.1.161", "PMC3983955", "17549417"]}, {"Citation": "Daud N.N.N.N.M., Septama A.W., Simbak N., Abu Bakar N.H., Rahmi E.P. Synergistic Effect of Flavonoids from Artocarpus heterophyllus Heartwoods on Anticancer Activity of Cisplatin Against H460 and MCF-7 Cell Lines. Nat. Prod. Sci. 2019;25:311\u2013316. doi: 10.20307/nps.2019.25.4.311.", "ArticleIdList": ["10.20307/nps.2019.25.4.311"]}, {"Citation": "Casanova A.G., Prieto M., Colino C.I., Guti\u00e9rrez-Mill\u00e1n C., Ruszkowska-Ciastek B., De Paz E., Mart\u00edn A., Morales A.I., L\u00f3pez-Hern\u00e1ndez F.J. A Micellar Formulation of Quercetin Prevents Cisplatin Nephrotoxicity. Int. J. Mol. Sci. 2021;22:729. doi: 10.3390/ijms22020729.", "ArticleIdList": ["10.3390/ijms22020729", "PMC7828436", "33450917"]}, {"Citation": "Ghavami G., Muhammadnejad S., Amanpour S., Sardari S. Fraction Bioactivity Screening of Mulberry Leaf and Two Flavonoids in Combination with Cisplatin on Human Gastric Adenocarcinoma Cells. Iran. J. Pharm. Res. 2020;19:371\u2013382. doi: 10.22037/IJPR.2020.1101087.", "ArticleIdList": ["10.22037/IJPR.2020.1101087", "PMC7667550", "33224244"]}, {"Citation": "Shahid M., Subhan F., Ahmad N., Sewell R.D. The flavonoid 6-methoxyflavone allays cisplatin-induced neuropathic allodynia and hypoalgesia. Biomed. Pharmacother. 2017;95:1725\u20131733. doi: 10.1016/j.biopha.2017.09.108.", "ArticleIdList": ["10.1016/j.biopha.2017.09.108", "28962077"]}, {"Citation": "Athira K.V., Madhana R.M., Lahkar M. Flavonoids, the Emerging Dietary Supplement against Cisplatin-Induced Nephrotoxicity. Chem. Biol. Interact. 2016;248:18\u201320.", "ArticleIdList": ["26876905"]}, {"Citation": "Tomar A., Vasisth S., Khan S.I., Malik S., Nag T., Arya D.S., Bhatia J. Galangin ameliorates cisplatin induced nephrotoxicity in vivo by modulation of oxidative stress, apoptosis and inflammation through interplay of MAPK signaling cascade. Phytomedicine. 2017;34:154\u2013161. doi: 10.1016/j.phymed.2017.05.007.", "ArticleIdList": ["10.1016/j.phymed.2017.05.007", "28899498"]}, {"Citation": "Kamel K.M., El-Raouf O.M.A., Metwally S.A., El-Latif H.A.A., El-Sayed M.E. Hesperidin and Rutin, Antioxidant Citrus Flavonoids, Attenuate Cisplatin-Induced Nephrotoxicity in Rats. J. Biochem. Mol. Toxicol. 2014;28:312\u2013319. doi: 10.1002/jbt.21567.", "ArticleIdList": ["10.1002/jbt.21567", "24819883"]}, {"Citation": "Ju S.M., Kang J.G., Bae J.S., Pae H.O., Lyu Y.S., Jeon B.H. The Flavonoid Apigenin Ameliorates Cisplatin-Induced Nephrotoxicity through Reduction of p53 Activation and Promotion of PI3K/Akt Pathway in Human Renal Proximal Tubular Epithelial Cells. Evid.-Based Complement. Altern. Med. 2015;2015:186436. doi: 10.1155/2015/186436.", "ArticleIdList": ["10.1155/2015/186436", "PMC4454761", "26089934"]}, {"Citation": "Wang S.-W., Xu Y., Weng Y.-Y., Fan X.-Y., Bai Y.-F., Zheng X.-Y., Lou L.-J., Zhang F. Astilbin ameliorates cisplatin-induced nephrotoxicity through reducing oxidative stress and inflammation. Food Chem. Toxicol. 2018;114:227\u2013236. doi: 10.1016/j.fct.2018.02.041.", "ArticleIdList": ["10.1016/j.fct.2018.02.041", "29471006"]}, {"Citation": "Li Q., Zhang Y., Yang Y., Huang S., Zou X., Wei C., Liang T., Zhong X. Panax notoginseng saponins reduces the cisplatin-induced acute renal injury by increasing HIF-1\u03b1/BNIP3 to inhibit mitochondrial apoptosis pathway. Biomed. Pharmacother. 2021;142:111965. doi: 10.1016/j.biopha.2021.111965.", "ArticleIdList": ["10.1016/j.biopha.2021.111965", "34385105"]}, {"Citation": "Fei B., Liu Z., Xie L., Lv L., Zhu W., Liu J., Dai Y., She W. Panax notoginseng Saponins protect auditory cells against cisplatin-induced ototoxicity by inducing the AKT/Nrf2 signaling-mediated redox pathway. Mol. Med. Rep. 2020;22:3533\u20133540. doi: 10.3892/mmr.2020.11390.", "ArticleIdList": ["10.3892/mmr.2020.11390", "32945421"]}, {"Citation": "Ma Z.-N., Li Y.-Z., Li W., Yan X.-T., Yang G., Zhang J., Zhao L.-C., Yang L.-M. Nephroprotective Effects of Saponins from Leaves of Panax quinquefolius against Cisplatin-Induced Acute Kidney Injury. Int. J. Mol. Sci. 2017;18:1407. doi: 10.3390/ijms18071407.", "ArticleIdList": ["10.3390/ijms18071407", "PMC5535899", "28703736"]}, {"Citation": "Man S., Lv P., Cui J., Liu F., Peng L., Ma L., Liu C., Gao W. Paris saponin II-induced paraptosis-associated cell death increased the sensitivity of cisplatin. Toxicol. Appl. Pharmacol. 2020;406:115206. doi: 10.1016/j.taap.2020.115206.", "ArticleIdList": ["10.1016/j.taap.2020.115206", "32835762"]}, {"Citation": "Liang X., Yang Y., Huang Z., Zhou J., Li Y., Zhong X. Panax notoginseng saponins mitigate cisplatin induced nephrotoxicity by inducing mitophagy via HIF-1\u03b1. Oncotarget. 2017;8:102989\u2013103003. doi: 10.18632/oncotarget.19900.", "ArticleIdList": ["10.18632/oncotarget.19900", "PMC5732705", "29262539"]}, {"Citation": "Koczurkiewicz P., Kla\u015b K., Grabowska K., Piska K., Rogowska K., Wojcik-Pszczo\u0142a K., Podolak I., Galanty A., Michalik M., P\u0119kala E. Saponins as chemosensitizing substances that improve effectiveness and selectivity of anticancer drug\u2014Minireview of in vitro studies. Phytother. Res. 2019;33:2141\u20132151. doi: 10.1002/ptr.6371.", "ArticleIdList": ["10.1002/ptr.6371", "31294509"]}, {"Citation": "Ren N., Chen L., Li B., Rankin G.O., Chen Y.C., Tu Y. Purified Tea (Camellia sinensis (L.) Kuntze) Flower Saponins Induce the p53-Dependent Intrinsic Apoptosis of Cisplatin-Resistant Ovarian Cancer Cells. Int. J. Mol. Sci. 2020;21:4324. doi: 10.3390/ijms21124324.", "ArticleIdList": ["10.3390/ijms21124324", "PMC7352341", "32560563"]}, {"Citation": "Avato P., Migoni D., Argentieri M., Fanizzi F.P., Tava A. Activity of Saponins from Medicago species Against HeLa and MCF-7 Cell Lines and their Capacity to Potentiate Cisplatin Effect. Anti-Cancer Agents Med. Chem. 2017;17:1508\u20131518. doi: 10.2174/1871520617666170727152805.", "ArticleIdList": ["10.2174/1871520617666170727152805", "28748756"]}, {"Citation": "Huang C., Yu Y. Synergistic Cytotoxicity of \u03b2-Elemene and Cisplatin in Gingival Squamous Cell Carcinoma by Inhibition of STAT3 Signaling Pathway. Med. Sci. Monit. 2017;23:1507\u20131513. doi: 10.12659/MSM.903783.", "ArticleIdList": ["10.12659/MSM.903783", "PMC5383012", "28355175"]}, {"Citation": "Fu Y.-H., Guo J.-M., Xie Y.-T., Hua J., Dai Y.-Y., Zhang W., Lin T.-C., Liu Y.-P. Structural characterization, antiproliferative and anti-inflammatory activities of alkaloids from the roots of Zanthoxylum austrosinense. Bioorg. Chem. 2020;102:104101. doi: 10.1016/j.bioorg.2020.104101.", "ArticleIdList": ["10.1016/j.bioorg.2020.104101", "32721778"]}, {"Citation": "Mon M.T., Yodkeeree S., Punfa W., Pompimon W., Limtrakul P. Alkaloids from Stephania venosa as Chemo-Sensitizers in SKOV3 Ovarian Cancer Cells via Akt/NF-\u03baB Signaling. Chem. Pharm. Bull. 2018;66:162\u2013169. doi: 10.1248/cpb.c17-00687.", "ArticleIdList": ["10.1248/cpb.c17-00687", "29386467"]}, {"Citation": "Qiu M., Xue C., Zhang L. Piperine Alkaloid Induces Anticancer and Apoptotic Effects in Cisplatin Resistant Ovarian Car-cinoma by Inducing G2/M Phase Cell Cycle Arrest, Caspase Activation and Inhibition of Cell Migration and PI3K/Akt/GSK3\u03b2 Signalling Pathway. JBUON. 2019;24:2316\u20132321.", "ArticleIdList": ["31983100"]}, {"Citation": "Sarkhosh-Inanlou R., Molaparast M., Mohammadzadeh A., Shafiei-Irannejad V. Sanguinarine enhances cisplatin sensitivity via glutathione depletion in cisplatin--resistant ovarian cancer (A2780) cells. Chem. Biol. Drug Des. 2019;95:215\u2013223. doi: 10.1111/cbdd.13621.", "ArticleIdList": ["10.1111/cbdd.13621", "31512406"]}, {"Citation": "Song T.-H., Chen X.-X., Lee C.K.-F., Sze S.C.-W., Feng Y.-B., Yang Z.-J., Chen H.-Y., Li S.-T., Zhang L.-Y., Wei G., et al. Dendrobine targeting JNK stress signaling to sensitize chemotoxicity of cisplatin against non-small cell lung cancer cells in vitro and in vivo. Phytomedicine. 2018;53:18\u201327. doi: 10.1016/j.phymed.2018.06.018.", "ArticleIdList": ["10.1016/j.phymed.2018.06.018", "30668397"]}, {"Citation": "Kuai C.-P., Ju L.-J., Hu P.-P., Huang F. Corydalis saxicola Alkaloids Attenuate Cisplatin-Induced Neuropathic Pain by Reducing Loss of IENF and Blocking TRPV1 Activation. Am. J. Chin. Med. 2020;48:407\u2013428. doi: 10.1142/S0192415X20500214.", "ArticleIdList": ["10.1142/S0192415X20500214", "32138533"]}, {"Citation": "Sioud F., Ben Toumia I., Lahmer A., Khlifi R., Dhaouefi Z., Maatouk M., Ghedira K., Chekir-Ghedira L. Methanolic extract of Ephedra alata ameliorates cisplatin-induced nephrotoxicity and hepatotoxicity through reducing oxidative stress and genotoxicity. Environ. Sci. Pollut. Res. 2020;27:12792\u201312801. doi: 10.1007/s11356-020-07904-3.", "ArticleIdList": ["10.1007/s11356-020-07904-3", "32008195"]}, {"Citation": "Zhu J., Xu J., Jiang L., Huang J., Yan J., Chen Y., Yang Q. Improved antitumor activity of cisplatin combined with Ganoderma lucidum polysaccharides in U14 cervical carcinoma--bearing mice. Kaohsiung J. Med. Sci. 2019;35:222\u2013229. doi: 10.1002/kjm2.12020.", "ArticleIdList": ["10.1002/kjm2.12020", "30958641"]}, {"Citation": "Ma Q., Xu Y., Tang L., Yang X., Chen Z., Wei Y., Shao X., Shao X., Xin Z., Cai B., et al. Astragalus Polysaccharide Attenuates Cisplatin-Induced Acute Kidney Injury by Suppressing Oxidative Damage and Mitochondrial Dysfunction. BioMed Res. Int. 2020;2020:2851349. doi: 10.1155/2020/2851349.", "ArticleIdList": ["10.1155/2020/2851349", "PMC6970487", "31998784"]}, {"Citation": "Li C., Caihong L., Liu C., Min J., Hu M., Guo W. Astragalus polysaccharides increase the sensitivity of SKOV3 cells to cisplatin. Arch. Gynecol. Obstet. 2017;297:381\u2013386. doi: 10.1007/s00404-017-4580-9.", "ArticleIdList": ["10.1007/s00404-017-4580-9", "29103194"]}, {"Citation": "Zhai Q.-L., Hu X.-D., Xiao J., Yu D.-Q. Astragalus polysaccharide may increase sensitivity of cervical cancer HeLa cells to cisplatin by regulating cell autophagy. China J. Chin. Mater. Medica. 2018;43:805\u2013812. doi: 10.19540/j.cnki.cjcmm.20171113.018.", "ArticleIdList": ["10.19540/j.cnki.cjcmm.20171113.018", "29600659"]}, {"Citation": "Neelam, Khatkar A., Sharma K.K. Phenylpropanoids and Its Derivatives: Biological Activities and Its Role in Food, Phar-maceutical and Cosmetic Industries. Crit. Rev. Food Sci. Nutr. 2020;60:2655\u20132675.", "ArticleIdList": ["31456411"]}, {"Citation": "Taofiq O., Gonz\u00e1lez-Param\u00e1s A.M., Barreiro M.F., Ferreira I.C.F.R., McPhee D.J. Hydroxycinnamic Acids and Their De-rivatives: Cosmeceutical Significance, Challenges and Future Perspectives, a review. Molecules. 2017;22:281", "ArticleIdList": ["PMC6155946", "28208818"]}, {"Citation": "Kumar M., Dahiya V., Kasala E.R., Bodduluru L.N., Lahkar M. The renoprotective activity of hesperetin in cisplatin induced nephrotoxicity in rats: Molecular and biochemical evidence. Biomed. Pharmacother. 2017;89:1207\u20131215. doi: 10.1016/j.biopha.2017.03.008.", "ArticleIdList": ["10.1016/j.biopha.2017.03.008", "28320087"]}, {"Citation": "Akdemir F.N.E., Albayrak M., \u00c7alik M., Bayir Y., G\u00fcl\u00e7in I. The Protective Effects of p-Coumaric Acid on Acute Liver and Kidney Damages Induced by Cisplatin. Biomedicines. 2017;5:18. doi: 10.3390/biomedicines5020018.", "ArticleIdList": ["10.3390/biomedicines5020018", "PMC5489804", "28536361"]}, {"Citation": "Abass S.A., Abdel-Hamid N.M., Abouzed T.K., El-Shishtawy M.M. Chemosensitizing effect of Alpinia officinarum rhizome extract in cisplatin-treated rats with hepatocellular carcinoma. Biomed. Pharmacother. 2018;101:710\u2013718. doi: 10.1016/j.biopha.2018.02.128.", "ArticleIdList": ["10.1016/j.biopha.2018.02.128", "29524879"]}, {"Citation": "Dong H.-B., Hou M., Ma W.-B., Zhang J.-X., Li Z.-Y., Luo H.-B., Tang K.-H., Cao S.-H. First total synthesis of a new phenylpropanoid glycoside: Natural cytotoxic compound from Cirsium japonicum. J. Asian Nat. Prod. Res. 2017;20:1154\u20131161. doi: 10.1080/10286020.2017.1379511.", "ArticleIdList": ["10.1080/10286020.2017.1379511", "28948834"]}, {"Citation": "Tandon V.K., Kumar S. Recent Development on Naphthoquinone Derivatives and Their Therapeutic Applications as Anti-cancer Agents. Expert Opin. Ther. Pat. 2013;23:1087\u20131108. doi: 10.1517/13543776.2013.798303.", "ArticleIdList": ["10.1517/13543776.2013.798303", "23651032"]}, {"Citation": "Wirth S., Rohbogner C.J., Cieslak M., Kazmierczak-Baranska J., Donevski S., Nawrot B., Lorenz I.-P. Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: Synthesis, structure, and biological activity. J. Biol. Inorg. Chem. 2009;15:429\u2013440. doi: 10.1007/s00775-009-0615-4.", "ArticleIdList": ["10.1007/s00775-009-0615-4", "20091072"]}, {"Citation": "Daltoe R., Madeira K., Herleinger A., Filho J., Rezende L., Cerri M., Guimares I., Valadao I., Teixeira S., Greco S., et al. 21 In Vitro Study of the Potential Antineoplastic Effect of Synthetic Naphthoquinones in Cisplatin-Resistant Ovarian Cancer Lineage. Maturitas. 2012;71:S23. doi: 10.1016/S0378-5122(12)70095-6.", "ArticleIdList": ["10.1016/S0378-5122(12)70095-6"]}, {"Citation": "Sunassee S.N., Veale C.G., Shunmoogam-Gounden N., Osoniyi O., Hendricks D.T., Caira M.R., de la Mare J.-A., Edkins A.L., Pinto A.V., J\u00fanior E.N.D.S., et al. Cytotoxicity of lapachol, \u03b2-lapachone and related synthetic 1,4-naphthoquinones against oesophageal cancer cells. Eur. J. Med. Chem. 2013;62:98\u2013110. doi: 10.1016/j.ejmech.2012.12.048.", "ArticleIdList": ["10.1016/j.ejmech.2012.12.048", "23353747"]}, {"Citation": "Vuki\u0107 M., Vukovic N.L., Obradovi\u0107 A., Popovic S., Zaric M., Djurdjevic P., Markovi\u0107 S., Baskic D.D. Naphthoquinone rich Onosma visianii Clem (Boraginaceae) root extracts induce apoptosis and cell cycle arrest in HCT-116 and MDA-MB-231 cancer cell lines. Nat. Prod. Res. 2017;32:2712\u20132716. doi: 10.1080/14786419.2017.1374271.", "ArticleIdList": ["10.1080/14786419.2017.1374271", "28882053"]}, {"Citation": "Shilnikova K., Piao M.J., Kang K.A., Ryu Y.S., Park J.E., Hyun Y.J., Zhen A.X., Jeong Y.J., Jung U., Kim I.G., et al. Shikonin induces mitochondria-mediated apoptosis and attenuates epithelial-mesenchymal transition in cisplatin-resistant human ovarian cancer cells. Oncol. Lett. 2018;15:5417\u20135424. doi: 10.3892/ol.2018.8065.", "ArticleIdList": ["10.3892/ol.2018.8065", "PMC5858079", "29563994"]}, {"Citation": "Ahmad S.N.S., Rashtchizadeh N., Argani H., Roshangar L., Haghjo A.G., Sanajou D., Panah F., Jigheh Z.A., Dastmalchi S., Mesgari-Abbasi M. Dunnione protects against experimental cisplatin-induced nephrotoxicity by modulating NQO1 and NAD+ levels. Free Radic. Res. 2018;52:808\u2013817. doi: 10.1080/10715762.2018.1475732.", "ArticleIdList": ["10.1080/10715762.2018.1475732", "29865885"]}, {"Citation": "Bagatell R., Beliakoff J., David C.L., Marron M.T., Whitesell L. Hsp90 inhibitors deplete key anti-apoptotic proteins in pediatric solid tumor cells and demonstrate synergistic anticancer activity with cisplatin. Int. J. Cancer. 2004;113:179\u2013188. doi: 10.1002/ijc.20611.", "ArticleIdList": ["10.1002/ijc.20611", "15455381"]}, {"Citation": "Tatokoro M., Koga F., Yoshida S., Kawakami S., Fujii Y., Neckers L., Kihara K. Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells. Int. J. Cancer. 2011;131:987\u2013996. doi: 10.1002/ijc.26475.", "ArticleIdList": ["10.1002/ijc.26475", "PMC7447157", "21964864"]}, {"Citation": "Costa T.E., Raghavendra N.M., Penido C. Natural heat shock protein 90 inhibitors in cancer and inflammation. Eur. J. Med. Chem. 2020;189:112063. doi: 10.1016/j.ejmech.2020.112063.", "ArticleIdList": ["10.1016/j.ejmech.2020.112063", "31972392"]}, {"Citation": "Banerji U., O\u2019Donnell A., Scurr M., Pacey S.C., Stapleton S., Asad Y., Simmons L., Maloney A., Raynaud F., Campbell M., et al. Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients with Advanced Malignancies. J. Clin. Oncol. 2005;23:4152\u20134161. doi: 10.1200/JCO.2005.00.612.", "ArticleIdList": ["10.1200/JCO.2005.00.612", "15961763"]}, {"Citation": "Ahmed E.A., Omar H.M., Elghaffar S.K.A., Ragb S.M., Nasser A.Y. The antioxidant activity of Vitamin C, DPPD and l-cysteine against Cisplatin-induced testicular oxidative damage in rats. Food Chem. Toxicol. 2011;49:1115\u20131121. doi: 10.1016/j.fct.2011.02.002.", "ArticleIdList": ["10.1016/j.fct.2011.02.002", "21310208"]}, {"Citation": "Zaied F.A., Elballat S.E. Reduction in the Formation of Micronucleated Polychromatic Erythrocytes Induced by Cisplatin in Bone Marrow Cells of Rats by using Antioxidants. Egypt. Acad. J. Biol. Sci. C Physiol. Mol. Biol. 2019;11:47\u201355. doi: 10.21608/eajbsc.2019.33962.", "ArticleIdList": ["10.21608/eajbsc.2019.33962"]}, {"Citation": "Leekha A., Gurjar B.S., Tyagi A., Rizvi M.A., Verma A.K. Vitamin C in synergism with cisplatin induces cell death in cervical cancer cells through altered redox cycling and p53 upregulation. J. Cancer Res. Clin. Oncol. 2016;142:2503\u20132514. doi: 10.1007/s00432-016-2235-z.", "ArticleIdList": ["10.1007/s00432-016-2235-z", "27613187"]}, {"Citation": "Rauf N., Nawaz A., Ullah H., Ullah R., Nabi G., Ullah A., Wahab F., Jahan S., Fu J. Therapeutic effects of chitosan-embedded vitamin C, E nanoparticles against cisplatin-induced gametogenic and androgenic toxicity in adult male rats. Environ. Sci. Pollut. Res. 2021;28:56319\u201356332. doi: 10.1007/s11356-021-14516-y.", "ArticleIdList": ["10.1007/s11356-021-14516-y", "34050519"]}, {"Citation": "Hui K., Li X., Xu R., Ye L., Kong H., Zeng X., Wang H., Xie W. The synergistic effect of resveratrol in combination with cisplatin on apoptosis via modulating autophagy in A549 cells. Acta Biochim. Biophys. Sin. 2016;48:528\u2013535. doi: 10.1093/abbs/gmw026.", "ArticleIdList": ["10.1093/abbs/gmw026", "PMC4913517", "27084520"]}, {"Citation": "Elsenduny F., Badria F.A., El-Waseef A.M., Chauhan S.C., Halaweish F. Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B. Tumor Biol. 2015;37:685\u2013698. doi: 10.1007/s13277-015-3773-8.", "ArticleIdList": ["10.1007/s13277-015-3773-8", "26242260"]}, {"Citation": "Kim S.H., Hong K.O., Hwang J.K., Park K.-K. Xanthorrhizol has a potential to attenuate the high dose cisplatin-induced nephrotoxicity in mice. Food Chem. Toxicol. 2005;43:117\u2013122. doi: 10.1016/j.fct.2004.08.018.", "ArticleIdList": ["10.1016/j.fct.2004.08.018", "15582203"]}, {"Citation": "Ibrahim A., Eldaim M.A., Abdel-Daim M. Nephroprotective effect of bee honey and royal jelly against subchronic cisplatin toxicity in rats. Cytotechnology. 2015;68:1039\u20131048. doi: 10.1007/s10616-015-9860-2.", "ArticleIdList": ["10.1007/s10616-015-9860-2", "PMC4960153", "25720368"]}, {"Citation": "Hsieh M.-J., Wang C.-W., Lin J.-T., Chuang Y.-C., Hsi Y.-T., Lo Y.-S., Lin C.-C., Chen M.-K. Celastrol, a plant-derived triterpene, induces cisplatin-resistance nasopharyngeal carcinoma cancer cell apoptosis though ERK1/2 and p38 MAPK signaling pathway. Phytomedicine. 2018;58:152805. doi: 10.1016/j.phymed.2018.12.028.", "ArticleIdList": ["10.1016/j.phymed.2018.12.028", "31022663"]}, {"Citation": "Zhang Y., Chen S., Wei C., Rankin G.O., Rojanasakul Y., Ren N., Ye X., Chen Y.C. Dietary compound proanthocyanidins from Chinese bayberry (Myrica rubra Sieb. et Zucc.) leaves inhibit angiogenesis and regulate cell cycle of cisplatin-resistant ovarian cancer cells via targeting Akt pathway. J. Funct. Foods. 2017;40:573\u2013581. doi: 10.1016/j.jff.2017.11.045.", "ArticleIdList": ["10.1016/j.jff.2017.11.045", "PMC5863932", "29576805"]}, {"Citation": "Stathopoulos G.P., Boulikas T. Lipoplatin Formulation Review Article. J. Drug Deliv. 2011;2012:581363. doi: 10.1155/2012/581363.", "ArticleIdList": ["10.1155/2012/581363", "PMC3166721", "21904682"]}, {"Citation": "Kim E.S., Lu C., Khuri F.R., Tonda M., Glisson B.S., Liu D., Jung M., Hong W.K., Herbst R.S. A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer. Lung Cancer. 2001;34:427\u2013432. doi: 10.1016/S0169-5002(01)00278-1.", "ArticleIdList": ["10.1016/S0169-5002(01)00278-1", "11714540"]}, {"Citation": "Baba M., Matsumoto Y., Kashio A., Cabral H., Nishiyama N., Kataoka K., Yamasoba T. Micellization of cisplatin (NC-6004) reduces its ototoxicity in guinea pigs. J. Control. Release. 2012;157:112\u2013117. doi: 10.1016/j.jconrel.2011.07.026.", "ArticleIdList": ["10.1016/j.jconrel.2011.07.026", "21807044"]}, {"Citation": "Dragovich T., Mendelson D., Hoos A., Lewis J., Kurtin S., Richardson K., Von Hoff D. 268 A phase II trial of aroplatin (L-NDDP), a liposomal DACH platinum, in patients with metastatic colorectal cancer (CRC)\u2014A preliminary report. Eur. J. Cancer Suppl. 2003;1:S82\u2013S83. doi: 10.1016/S1359-6349(03)90301-6.", "ArticleIdList": ["10.1016/S1359-6349(03)90301-6"]}, {"Citation": "Sandhiutami N.M.D., Arozal W., Louisa M., Rahmat D., Wuyung P.E. Curcumin Nanoparticle Enhances the Anticancer Effect of Cisplatin by Inhibiting PI3K/AKT and JAK/STAT3 Pathway in Rat Ovarian Carcinoma Induced by DMBA. Front. Pharmacol. 2021;11:2199. doi: 10.3389/fphar.2020.603235.", "ArticleIdList": ["10.3389/fphar.2020.603235", "PMC7848208", "33536913"]}, {"Citation": "Guven A., Villares G.J., Hilsenbeck S.G., Lewis A., Landua J., Dobrolecki L.E., Wilson L.J., Lewis M.T. Carbon nanotube capsules enhance the in vivo efficacy of cisplatin. Acta Biomater. 2017;58:466\u2013478. doi: 10.1016/j.actbio.2017.04.035.", "ArticleIdList": ["10.1016/j.actbio.2017.04.035", "PMC6344128", "28465075"]}, {"Citation": "Ibarra J., Encinas D., Blanco M., Barbosa S., Taboada P., Juarez J.E., Valdez M.A. Co-encapsulation of magnetic nanoparticles and cisplatin within biocompatible polymers as multifunctional nanoplatforms: Synthesis, characterization, andin vitroassays. Mater. Res. Express. 2017;5:015023. doi: 10.1088/2053-1591/aaa0a4.", "ArticleIdList": ["10.1088/2053-1591/aaa0a4"]}, {"Citation": "Saber M.M., Al-Mahallawi A.M., Nassar N., Stork B., Shouman S.A. Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes. BMC Cancer. 2018;18:822. doi: 10.1186/s12885-018-4727-5.", "ArticleIdList": ["10.1186/s12885-018-4727-5", "PMC6094476", "30111296"]}, {"Citation": "Mondal J., Kumar Panigrahi A., Rahman Khuda-Bukhsh A., Rahman Khuda A. Physico-Chemical and Ultra-Structural Characterizations of PLGA-Loaded Nanoparticles of Boldine and Their Efficacy in Ameliorating Cisplatin Induced Hepato-toxicity in Normal Liver Cells in Vitro. J. Innov. Pharm. Biol. Sci. 2015;2:506\u2013521."}, {"Citation": "Yavuz B., Zeki J., Taylor J., Harrington K., Coburn J.M., Ikegaki N., Kaplan D.L., Chiu B. Silk Reservoirs for Local Delivery of Cisplatin for Neuroblastoma Treatment: In Vitro and In Vivo Evaluations. J. Pharm. Sci. 2019;108:2748\u20132755. doi: 10.1016/j.xphs.2019.03.019.", "ArticleIdList": ["10.1016/j.xphs.2019.03.019", "PMC6640112", "30905702"]}, {"Citation": "Lozano-P\u00e9rez A.A., Gil A.L., P\u00e9rez S.A., Cutillas N., Meyer H., Pedre\u00f1o M., Aznar-Cervantes S.D., Janiak C., Cenis J.L., Ruiz J. Antitumor properties of platinum(iv) prodrug-loaded silk fibroin nanoparticles. Dalton Trans. 2015;44:13513\u201313521. doi: 10.1039/C5DT00378D.", "ArticleIdList": ["10.1039/C5DT00378D", "25799077"]}, {"Citation": "Zhen X., Wang X., Xie C., Wu W., Jiang X. Cellular uptake, antitumor response and tumor penetration of cisplatin-loaded milk protein nanoparticles. Biomaterials. 2013;34:1372\u20131382. doi: 10.1016/j.biomaterials.2012.10.061.", "ArticleIdList": ["10.1016/j.biomaterials.2012.10.061", "23158934"]}, {"Citation": "Etman S.M., Elnaggar Y.S.R., Abdallah O.Y. Fucoidan, a natural biopolymer in cancer combating: From edible algae to nanocarrier tailoring. Int. J. Biol. Macromol. 2020;147:799\u2013808. doi: 10.1016/j.ijbiomac.2019.11.191.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.11.191", "31770552"]}, {"Citation": "Hsu H.-Y., Lin T.-Y., Hu C.-H., Shu D.T.F., Lu M.-K. Fucoidan upregulates TLR4/CHOP-mediated caspase-3 and PARP activation to enhance cisplatin-induced cytotoxicity in human lung cancer cells. Cancer Lett. 2018;432:112\u2013120. doi: 10.1016/j.canlet.2018.05.006.", "ArticleIdList": ["10.1016/j.canlet.2018.05.006", "29746926"]}, {"Citation": "Kim H.J., Yoon Y.M., Lee J.H., Lee S.H. Protective Role of Fucoidan on Cisplatin-mediated ER Stress in Renal Proximal Tubule Epithelial Cells. Anticancer Res. 2019;39:5515\u20135524. doi: 10.21873/anticanres.13744.", "ArticleIdList": ["10.21873/anticanres.13744", "31570445"]}, {"Citation": "Song M.Y., Ku S.K., Kim H.J., Han J.S. Low molecular weight fucoidan ameliorating the chronic cisplatin-induced delayed gastrointestinal motility in rats. Food Chem. Toxicol. 2012;50:4468\u20134478. doi: 10.1016/j.fct.2012.09.020.", "ArticleIdList": ["10.1016/j.fct.2012.09.020", "23022014"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "4"}, {"Year": "2022", "Month": "1", "Day": "20"}, {"Year": "2022", "Month": "1", "Day": "24"}, {"Year": "2022", "Month": "2", "Day": "15", "Hour": "1", "Minute": "17"}, {"Year": "2022", "Month": "2", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["35163459", "PMC8835907", "10.3390/ijms23031532", "ijms23031532"]}}], "PubmedBookArticle": []}